Hospital sterilisation services firm Synergy Health said underlying organic growth has been challenging amid the slowdown in the UK, economic pressures in Europe and currency effects but trading in the first half of the year remains on track.
The Swindon, UK-based provider of outsourced sterilisation services to the medical device market and healthcare sector said margins have continued to improve, resulting in solid earnings growth.
Synergy, which provides decontamination services for reusable medical & surgical equipment and hospital linen management throughout the UK and Netherlands, added that the integration of SRI in the US is progressing positively.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
It said SRI is operating profitably after it was de-listed from Nasdaq and trading has improved over the last 10 weeks following the introduction of Synergy's new strategy to rebuild margin and growth.
However the group noted that at the time of the acquisition it was expecting operating margins to reach 10% within 18 months, but it now expects to achieve this by March 31st 2013.
CJ
-
Should you sell in May this year?The market adage looks unlikely to apply in 2024, and global equities are proving resilient
-
Should you invest in UK equities?The FTSE 100 hit a record high this week, but UK equities remain unloved and undervalued compared to their global and US peers. Should you snap them up at a discount?
